Evidence map›Paper›PMID 33911479›Full record

ArticleAnnals of dermatology2018

Identification of

Edoardo Torres-Guerrero, Elisa Crystal Sánchez-Moreno, Carlos Enrique Atoche-Diéguez, Erika Margarita Carrillo-Casas, Roberto Arenas, Juan Xicohtencatl-Cortes, Rigoberto Hernández-Castro

Open access · hybridAbstract read
In one paragraph

Article in Annals of dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Frontiers in microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Edoardo Torres-GuerreroMycology Service, Dermatological Center of Yucatan Dr. Fernando Latapi, Yucatan 97000, Mexico.
Elisa Crystal Sánchez-MorenoMycology Service, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
Carlos Enrique Atoche-DiéguezMycology Service, Dermatological Center of Yucatan Dr. Fernando Latapi, Yucatan 97000, Mexico.
Erika Margarita Carrillo-CasasDepartment of Molecular Biology and Histocompatibility, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
Roberto ArenasMycology Service, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.
Juan Xicohtencatl-CortesIntestinal Bacteriology Laboratory, Childrens Hospital of Mexico Dr. Federico Gomez, Mexico City 06720, Mexico.
Rigoberto Hernández-CastroDepartment of Ecology of Pathogen Agents, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.ORCID https://orcid.org/0000-0002-5656-0942
Hospital General Dr. Manuel Gea Gonzalez · MXAutonomous University of Yucatán · MXHospital Infantil de México Federico Gómez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe causative agents of leprosy are the well-known

objectiveThe objective of this work was to determine if

methodsA total of 41 skin samples were obtained from 11 states of Mexico. All patients' samples were diagnosed by clinical and histopathological analyses. Total DNA was isolated using a Qiagen-DNeasy blood and tissue kit and molecular identification was achieved by two semi-nested polymerase chain reactions.

resultsThe 41 patient included 33 samples from men and 8 samples from women; 29 samples were polymerase chain reaction (PCR)-positive to

conclusionThese findings add evidence to the

Indexed as

Diffuse lepromatous leprosyLeprosyMycobacterium lepraeMycobacterium lepromatosisNodular lepromatous leprosy

Identifiers

PMID33911479
PMCPMC7992488
OpenAlexW2889259755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.